Strong response to first-line osimertinib and chemotherapy in EGFR L861Q-mutant NSCLC: a case report

Current Problems in Cancer: Case Reports · Published 2026-07-13 · DOI 10.1016/j.cpccr.2026.100431

Free full text

Authors (3)

Pranav Ravipati, Rizvan Azimzade, Missak Haigentz

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ravipati, P., Azimzade, R., Haigentz, M. (2026). Strong response to first-line osimertinib and chemotherapy in EGFR L861Q-mutant NSCLC: a case report. Current Problems in Cancer: Case Reports. https://doi.org/10.1016/j.cpccr.2026.100431

Related articles